Satellos Bioscience【MSCL】銘柄情報

個人投資家向けのプロ仕様のツール。

プレミアム

通貨

0.75

買値

0.72

売値

0.78

出来高

351,193

0.67 日の範囲 0.82

0.38 52 週間の範囲 0.90

時価総額

84.594M

前日終値

0.81

始値

0.82

時刻

3500

0.75

最終取引時間

財務取引量

VWAP

平均取引量 (3 か月)

131,415

発行済株式数

112,792,000

配当利回り

PER

-5.32

1 株当たり利益 (EPS)

-0.14

歳入

純利益

-15.89M

セクター

Coml Physical, Biologcl Resh

業界

Pharmaceutical Preparations

ウェブサイト

www.satellos.com

本社

Toronto, Ontario, Can

設立

2007

Satellos Bioscience Inc is listed in the Coml Physical, Biologcl Resh sector of the トロント証券取引所 with ticker MSCL. The last closing price for Satellos Bioscience was $0.81. Over the last year, Satellos Bioscience shares have traded in a share price range of $ 0.38 to $ 0.90.

Satellos Bioscience currently has 112,792,000 shares in issue. The market capitalisation of Satellos Bioscience is $91.36 million. Satellos Bioscience has a price to earnings ratio (PE ratio) of -5.32.

Satellos Appoints Stephanie Brown to Board of Directors

Satellos Bioscience Inc. (TSX: MSCL) (OTCQB: MSCLF) (“Satellos” or the “Company”), a public biotech company developing new small molecule therapeutic approaches to improve the treatment of muscle...

Satellos Reports Q3 2024 Financial Results and Provides Clinical Update

- Completed enrollment for SAT-3247 in Duchenne muscular dystrophy (DMD) in the first three (of five) single-ascending dose (SAD) cohorts with no safety concerns and initiated enrollment of first...

Satellos to Participate in November 2024 Investor Conferences

Satellos Bioscience Inc. (“Satellos” or the “Company”) (TSX: MSCL) (OTCQB: MSCLF), a public biotech company developing new small molecule therapeutic approaches to improve the treatment of muscle...

Satellos Demonstrates Treatment of DMD Canines with SAT-3247 Improved Measures of Strength to Near Normal Levels

- Analysis showed improvement in muscle morphology and increased levels of regeneration in muscle groups, including the diaphragm, quadriceps, and calf - No adverse events and no significant...

Satellos Announces Dosing of First Participant in Phase 1 Clinical Study of SAT-3247

- The first healthy volunteer has been dosed in the first component of the Phase 1 study - Initial safety and pharmacokinetic data expected in Q4 2024 - Initiation of the second component of...

Satellos Announces Participation in September 2024 Investor Conferences

Satellos Announces Acceptance of Regulatory Filing to Commence a Phase 1 Clinical Trial with SAT-3247

Dosing of first participant in a Phase 1 clinical trial of SAT-3247 anticipated in Q3 2024 Satellos Bioscience Inc. (“Satellos” or the “Company”) (TSX: MSCL, OTCQB: MSCLF), a public biotech...

Satellos Announces Q2 2024 Financial Results and Updated Canine Data

- Updated data in a canine model of Duchenne muscular dystrophy (DMD) show further increased improvement in muscle force over baseline of 195% at four-month point - Receipt of Orphan Drug and...

Satellos Receives Rare Pediatric Disease Designation from the U.S. FDA for SAT-3247 for the Treatment of Duchenne Muscular Dystrophy

– SAT-3247 is a proprietary, oral small molecule drug being developed by Satellos as a novel treatment to regenerate skeletal muscle which is lost in Duchenne muscular dystrophy (DMD) – DMD is a...

期間 †	前日比	前日比 %	始値	高値	安値	平均出来高	VWAP
1	-0.08	-9.63855421687	0.83	0.85	0.67	111964	0.80028132	CS
4	0	0	0.75	0.9	0.67	119098	0.83104853	CS
12	0.22	41.5094339623	0.53	0.9	0.45	131415	0.68572591	CS
26	0.27	56.25	0.48	0.9	0.45	91490	0.62797361	CS
52	0.13	20.9677419355	0.62	0.9	0.38	82552	0.60781725	CS
156	0.13	20.9677419355	0.62	0.9	0.38	82552	0.60781725	CS
260	0.13	20.9677419355	0.62	0.9	0.38	82552	0.60781725	CS

出来高
値上がり率
値下がり率

銘柄コード	株価	出来高
AABAberdeen International Inc	$ 0.065 (18.18%)	226.54k
MDPMedexus Pharmaceuticals Inc	$ 2.45 (15.02%)	46.31k
NCFNorthcliff Resources Ltd	$ 0.04 (14.29%)	5k
SAMStarcore International Mines Ltd	$ 0.16 (14.29%)	200k
GECGlobal Education Communities Corp	$ 0.225 (12.50%)	60k
BNGBengal Energy Ltd	$ 0.005 (-50.00%)	20k
RTGRTG Mining Inc	$ 0.03 (-25.00%)	13k
SMCSulliden Mining Capital Inc	$ 0.015 (-25.00%)	200k
APSAptose Biosciences Inc	$ 0.27 (-20.59%)	346.55k
FLNTFlint Corporation	$ 0.025 (-16.67%)	28k
SUSuncor Energy Inc	$ 58.04 (0.94%)	14.14M
MFCManulife Financial Corporation	$ 45.42 (-0.53%)	9.73M
SLFSun Life Financial Inc	$ 85.54 (-0.23%)	6.19M
BITFBitfarms Ltd	$ 2.96 (3.14%)	6.17M
CNQCanadian Natural Resources Ltd	$ 48.70 (0.83%)	4.91M